Longitudinal changes in prostate volume in a community-based cohort study of middle-aged and elderly men in rural China

被引:1
作者
Liang, Q. -F. [1 ]
Zhang, S. -C. [2 ]
Yu, X. -H. [3 ]
Li, J. -H. [1 ]
Zheng, J. -B. [3 ]
Zhao, J. [4 ]
Liang, G. -Q. [5 ]
Shi, H. -J. [1 ]
Zhou, W. -J. [1 ]
Zhu, Q. -X. [1 ]
机构
[1] Fudan Univ, Shanghai Inst Planned Parenthood Res, Dept Reprod Epidemiol & Social Sci, NHC Key Lab Reprod Regulat, 779 Old Humin Rd, Shanghai 200237, Peoples R China
[2] Natl Res Inst Family Planning, Dept Cell Biol, Beijing, Peoples R China
[3] First Peoples Hosp Jiashan, Dept Urol, Jiaxing, Zhejiang, Peoples R China
[4] Lanzhou Univ, Hosp 1, Dept Cardiol, Key Lab Cardiovasc Dis, Lanzhou, Peoples R China
[5] Fudan Univ, Obstet & Gynecol Hosp, Dept Urol, Shanghai, Peoples R China
基金
上海市自然科学基金;
关键词
prostate volume; prostate volume change rate; baseline characteristics; prostate-specific antigen; age; URINARY-TRACT SYMPTOMS; HYPERPLASIA; ANTIGEN; PROGRESSION; RATES;
D O I
10.1111/andr.12711
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background Prostate volume (PV) and its change rate are important for the progression of prostate disease, but studies on their estimates are inconsistent. Objectives To investigate whether age, prostate-specific antigen (PSA), and other specific characteristics are associated with PV and its change rate. Materials and Methods A community-based cohort study was conducted in a rural area of China among male residents aged 40-80 years. PV was estimated at baseline and at 4 years of follow-up by trans-abdominal ultrasound. Annual PV change rate (PVCR) was calculated as change in volume divided by time interval. Baseline characteristics, including age, serum PSA, and hormones, were evaluated. And their relationships with PV or PVCR were assessed with Pearson correlation and multivariate linear regression analyses. Results Totally, 462 participants completed the follow-up with baseline PV (PV0) of 15.6 +/- 5.5 ml. PV0 was highly correlated with age and PSA in pairwise correlations (Pearson r = 0.35 and 0.34, respectively, p < 0.01). Multivariate linear regression showed similar associations that PV0 tended to increase with age and PSA. The average PVCR was 0.7 +/- 1.8 ml/year. In pairwise correlations, PVCR was inversely correlated with PV0 and positively correlated with PSA, while it was not significantly related to baseline age. Linear regression of PVCR on age and PSA in groups classified by PV0 quartile showed that age was not a significant estimator of PVCR, whereas PSA was. In each PV0 group, PVCR tended to increase with PSA. Discussion and Conclusion PV was positively associated with age and PSA, and it tended to grow faster in men with smaller baseline PV and higher PSA. PSA can be a valuable parameter for estimating both the size and the growth speed of prostate. Although age is associated with prostate enlargement, it does not appear to be related to the longitudinal change rate of PV.
引用
收藏
页码:358 / 363
页数:6
相关论文
共 30 条
[1]   The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: The Krimpen study [J].
Bosch, J. L. H. Ruud ;
Bangma, Chris H. ;
Groeneveld, Frans P. M. J. ;
Bohnen, Arthur M. .
EUROPEAN UROLOGY, 2008, 53 (04) :819-827
[2]   The role of dihydrotestosterone in benign prostatic hyperplasia [J].
Carson, C ;
Rittmaster, R .
UROLOGY, 2003, 61 (04) :2-7
[3]   The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care [J].
Choi, Edmond P. H. ;
Lam, Cindy L. K. ;
Chin, Weng-Yee .
QUALITY OF LIFE RESEARCH, 2014, 23 (10) :2723-2733
[4]   Prostate volume ultrasonography: The influence of transabdominal versus transrectal approach, device type and operator [J].
Chung, JWNCHF ;
de Vries, SH ;
Raaijmakers, R ;
Postma, R ;
Bosch, JLHR ;
van Mastrigt, R .
EUROPEAN UROLOGY, 2004, 46 (03) :352-356
[5]   ROBUST LOCALLY WEIGHTED REGRESSION AND SMOOTHING SCATTERPLOTS [J].
CLEVELAND, WS .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1979, 74 (368) :829-836
[6]   Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo [J].
Crawford, ED ;
Wilson, SS ;
McConnell, JD ;
Slawin, KM ;
Lieber, MC ;
Smith, JA ;
Meehan, AG ;
Bautista, OM ;
Noble, WR ;
Kusek, JW ;
Nyberg, LM ;
Roehrborn, CG .
JOURNAL OF UROLOGY, 2006, 175 (04) :1422-1426
[7]   Internal Prostatic Architecture on Transrectal Ultrasonography Predicts Future Prostatic Growth: Natural History of Prostatic Hyperplasia in a 15-Year Longitudinal Community-Based Study [J].
Fukuta, Fumimasa ;
Masumori, Naoya ;
Mori, Mitsuru ;
Tsukamoto, Taiji .
PROSTATE, 2011, 71 (06) :597-603
[8]   Prostate size: Is size all that matters? (When does size matter?) [J].
Ho, Evelyn L. M. ;
Tong, Seng Fah ;
Tan, Hui Meng .
JOURNAL OF MENS HEALTH, 2011, 8 :S22-S24
[9]   Racial differences in pathogenetic mechanisms, prevalence, and progression of benign prostatic hyperplasia [J].
Hoke, Gerald ;
Baker, William ;
Barnswell, Carlton ;
Bennett, James ;
Davis, Rodney ;
Mason, Terry ;
Rayford, Walter .
UROLOGY, 2006, 68 (05) :924-930
[10]  
HOUGH D M, 1991, Australasian Radiology, V35, P358, DOI 10.1111/j.1440-1673.1991.tb03047.x